My WordPress Blog
Jeff Yass and Ken Griffin are in a league of their own. Yass is the co-founder and managing director at the global quantitative trading firm Susquehanna International Group, while Griffin is CEO of the massive “pod shop” hedge fund Citadel. Both billionaires have built financial empires and are quite skilled at their trade. That’s why ...
Flux Power Holdings, Inc. FLUX, a developer of advanced lithium-ion energy storage solutions for electrification of commercial and industrial equipment, today announced that on November 20, 2024, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with requirements of ...
Microsoft Corp. MSFT, the heavyweight of Big Tech, has hit a grim milestone in technical analysis: a Death Cross. With its share price slipping below key moving averages, MSFT stock has moved into bearish territory, casting doubts on its near-term prospects. Is this just a blip for the software giant, or the prelude to deeper ...
Elite Pharmaceuticals Inc. (ELTP) fits nicely into the nexus of the increasing diagnoses of ADHD and the patent expiration of the branded drug Vyanse in 2023 for its treatment. Elite Pharmaceuticals Inc. recently received FDA approval for its generic version of Vyanse and expects to launch the product in early 2025. Image Source: Zacks Investment ...
Nvidia Corporation‘s (NASDAQ: NVDA) shares dipped 3.4% in response to its fiscal 2025 third-quarter results last week, but I see this modest move lower as an opportunity to add to my position. While analysts project the company’s revenue growth to slow from 111.9% in fiscal 2025 to 49.2% in fiscal 2026, I remain convinced of ...
Optimism is climbing, but are valuations too high? Key risk indicators signal caution as sentiment soars. Investors face a tough balancing act in today’s market. The market has come a long way since the October 2022 low, with optimism creeping back in. But with this renewed confidence comes a need to tread carefully. As investor ...
With a market cap of $35.8 billion, ResMed Inc. (RMD) is a global leader in the design, manufacturing, and distribution of medical devices and cloud-based software for the treatment of sleep-disordered breathing (SDB) and other respiratory conditions. It operates through two segments: Sleep and Respiratory Care, and Software-as-a-Service, offering innovative products and solutions for respiratory health ...
Nvidia (NASDAQ: NVDA) did it again. The AI chip superstar delivered another round of smashing results, easily beating estimates in its third-quarter earnings report on Nov. 20. Revenue jumped 94% in the quarter to $35.1 billion, which topped the consensus at $33.1 billion, and adjusted earnings per share (EPS) more than doubled from $0.40 to ...
The Law Offices of Frank R. Cruz reminds investors of the upcoming November 25, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Metagenomi, Inc. (“Metagenomi” or the “Company”) MGX securities pursuant and/or traceable to the Company’s February 2024 initial public offering (the “IPO”). If ...
Eli Lilly and Co. LLY has seen better days. The stock is up 26.04% for the last year but has struggled recently, falling 17.57% over the last month. Chart created using Benzinga Pro Lilly stock is well below its summer highs and is trading at $746.94 at the time of writing. The once red-hot obesity ...
The whipping post
The whipping post
